|
|
Volumn 159, Issue 22, 1999, Pages 2631-2632
|
|
Data vs opinion, phenytoin vs fosphenytoin: The saga continues
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FOSPHENYTOIN SODIUM;
PHENYTOIN;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG CHOICE;
DRUG COST;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
EDITORIAL;
HEART ARRHYTHMIA;
HUMAN;
PRIORITY JOURNAL;
SKIN NECROSIS;
THROMBOPHLEBITIS;
ADULT;
ALGORITHMS;
ANTICONVULSANTS;
CHILD;
CONSENSUS DEVELOPMENT CONFERENCES;
DRUG INDUSTRY;
HUMANS;
PHENYTOIN;
RESEARCH SUPPORT;
SAFETY;
SEIZURES;
|
|
EID: 0033611313
PISSN: 00039926
EISSN: None
Source Type: Journal
DOI: 10.1001/archinte.159.22.2631 Document Type: Editorial |
|
Times cited : (2)
|
|
References (12)
|
